BridgeBio’s oncology spinoff swaps out CEOs as it seeks to accelerate KRAS work

BridgeBio Oncology Therapeutics is replacing CEO Eli Wallace, putting its CSO Pedro Beltran in the role, and making board member Neil Kumar executive chairman. The changes come as there’s been growing competition in cancer over ...